Revista de Psiquiatria y Salud Mental

Papers
(The median citation count of Revista de Psiquiatria y Salud Mental is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Detección de ansiedad y depresión en Atención Primaria: utilidad de 2 escalas breves adaptadas a los nuevos criterios CIE-11-AP136
Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis82
Waiting for Godot or the use of biomarkers in clinical practice33
A clozapine's uncharted voyage: Five years and a pandemic after the end of mandatory haematological notifications to the Spanish medicines agency29
Comparación de la discapacidad entre trastornos mentales graves y comunes usando la escala WHODAS 2.027
Estabilidad diagnóstica en la psicosis inducida por sustancias18
Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Usefu16
Long-term mental health impact of COVID-19 on primary care health workers in northern Spain: Results from a two-phase longitudinal study16
De la modificación de la capacidad a la provisión de apoyos en personas con discapacidad13
Perfil proteómico y metabólico de pacientes crónicos con esquizofrenia tras un programa de actividad física: estudio piloto12
Forma corta de cuatro subtest de la WAIS-IV para la evaluación de pacientes con diagnóstico de esquizofrenia12
Antidepressants overuse in primary care: Prescription trends between 2010 and 2019 in Catalonia11
Clozapina en pacientes con trastorno esquizoafectivo: una revisión sistemática10
El efecto de la ocupación laboral en la incidencia de demencia vascular: un estudio de cohortes de 12 años de seguimiento10
Towards a classification framework for patient safety incidents and adverse events for a mental health community-based model of service provision10
Sensibilidad y especificidad de los criterios diagnósticos DSM-5 en el trastorno del espectro autista en una muestra de niños y adolescentes españoles10
Digital mental health interventions for anxiety and depressive symptoms in university students during the COVID-19 pandemic: A systematic review of randomized controlled trials9
Is intensive home-treatment a real alternative to classical hospitalization for managing acute psychiatric processes? Insights from clinical practice8
Striatal volumes as potential biomarkers in Eating Disorders: A pilot study8
Risk factors of deficit and non-deficit schizophrenia: Results from a cross-sectional study8
La Convención de Naciones Unidas sobre los Derechos de las Personas con Discapacidad: los efectos del debate8
Mortalidad por COVID-19 y su relación con las búsquedas en internet sobre salud mental durante el primer año de pandemia8
ECT: A decision to decrease risks during COVID-19 pandemic7
¿Son concluyentes los estudios epidemiológicos de suicidio en España?7
Characteristics of patients treated for suicidal behavior during the pandemic in a psychiatric emergency department in a Spanish province6
Schizophrenia and the COVID-19 pandemic: A narrative review from the biomedical perspective6
Obsessive–compulsive symptoms in anxiety and depressive disorders: Influence of recent and/or traumatic life events6
Depression in late life: Linking the immunometabolic dysregulation with clinical features6
Psychiatrists as internists: Some considerations following a COVID-19 redeployment experience6
Frontal lobes dysfunction across clinical clusters of acute schizophrenia6
Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia5
Volume alterations of the hippocampus and amygdala in patients with schizophrenia and persistent auditory hallucinations5
Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries5
Ketamine triggers rapid antidepressant effects by modulating synaptic plasticity in a new depressive-like mouse model based on astrocyte glutamate transporter GLT-1 knockdown in infralimbic cortex5
Following a healthy/balanced diet predicts lower anxiety and depression during the COVID-19 pandemic5
Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: Rationale and design of a prospective, randomized, 3-phase, investigator-initiated study (PAFIP-3)5
Mental health interventions for healthcare workers during the first wave of COVID-19 pandemic in Spain4
High levels of TNF-α are associated with symptoms of depression in health professionals at a hospital4
Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia3
Mejora de la efectividad de la terapia electroconvulsiva mediante la determinación de la profundidad anestésica. Resultados preliminares3
Dried Blood Spot (DBS) as a useful tool to improve clozapine, aripiprazole and paliperidone treatment: From adherence to efficiency3
A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levels3
Informing the response to COVID-19 in Spain: priorities for mental health research3
The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design3
Amerindians may need clozapine dosing similar to that of Asians3
Estimation of the epidemiology of dementia and associated neuropsychiatric symptoms by applying machine learning to real-world data3
The impact of COVID-19 pandemic on the psychological well-being among health care workers: A 6-month cohort longitudinal survey study3
Precuneus and insular hypoactivation during cognitive processing in first-episode psychosis: Systematic review and meta-analysis of fMRI studies3
Clozapine for the treatment of pediatric encephalopathy associated with nonketotic hyperglycinemia3
0.033550977706909